Clinical trials
Continuous Glucose Monitoring System clinical trials
Below are recruiting continuous glucose monitoring system clinical trials, each written for real people, not researchers. We’re tracking 38 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05149625Recruiting
Compare glucose tracking with a sensor versus finger sticks
This study compares two ways to monitor blood sugar after partial or full pancreas removal: a continuous glucose sensor versus traditional finger-stick testing. It looks at both how well blood sugar is controlled and how satisfied people feel with each method.
SeoulAges 19 years+ - NCT07822945Recruiting
Diabetes technology knowledge among healthcare workers
This study asks healthcare workers at a specific hospital about what they know about diabetes technology. It aims to find gaps in knowledge so better training can be given.
ThessalonikiAges Any age - NCT07814508Recruiting
Continuous glucose monitor app study for insulin users
This study tests a new continuous glucose monitor (CGM) system with a predictive app to help people on insulin therapy manage their blood sugar better. It aims to see if the app improves daily life and glucose control.
Bad Mergentheim, Baden-WurttembergAges 18 years+ - NCT07745244Recruiting
Accuracy of a continuous glucose monitoring system
This trial tests a new continuous glucose monitor that checks blood sugar levels without frequent finger pricks. It aims to see how accurate and safe it is for people with type 1 diabetes.
Zibo, ShandongAges 18 years+ - NCT06468865Recruiting
Glucose monitoring for low blood sugar after gastric bypass
This trial tests whether a new way of using glucose monitoring can help manage low blood sugar that happens after meals in people who have had gastric bypass surgery. It aims to find better ways to track and treat these episodes.
Tønsberg, VestfoldAges 18 years+ - NCT07655076RecruitingEarly Phase 1
Smart insulin delivery study for type 1 diabetes
This study tests a system that measures blood sugar and automatically adjusts insulin delivery. It is for adults with type 1 diabetes who use insulin injections or a pump.
Toronto, OntarioAges 18 years+ - NCT06591286Recruiting
Real-time CGM for blood sugar after hospital discharge
This trial tests whether using a continuous glucose monitor (CGM) when you leave the hospital helps control blood sugar better. If you have type 2 diabetes and use insulin, you may be able to join.
Shanghai, Shanghai MunicipalityAges 18–80 - NCT07611721Recruiting
Testing a glucose monitor in critically ill surgery patients
This study tests whether a wearable glucose monitor (Dexcom G7) works well in patients in intensive care after major abdominal surgery or organ transplant who need insulin therapy. The monitor measures blood sugar continuously to help doctors manage insulin doses more safely.
PragueAges 18 years+ - NCT07518004Recruiting
ROME GS System Study for diabetes glucose monitoring
This study tests the ROME GS System, a glucose monitoring device that measures blood sugar levels. The system includes a sensor placed under the skin and a transmitter worn on the body. If you have diabetes and want to help evaluate a new way to track your blood sugar, this trial may be for you.
Escondido, CaliforniaAges 18 years+ - NCT06668935Recruiting
Using a continuous glucose monitor to help stick with GLP-1 meds
This study tests whether using a continuous glucose monitor (CGM) like the FreeStyle Libre 3 helps people with type 2 diabetes stay on their new GLP-1 or GIP/GLP-1 medication longer. You must be starting a GLP-1 or GIP/GLP-1 drug for the first time and not already using a CGM.
Jacksonville, FloridaAges 18 years+ - NCT07448805Recruiting
Accuracy and safety of a glucose monitor in the ICU
This trial tests a continuous glucose monitoring system (Syai Tag) in the intensive care unit (ICU). It aims to see how well it measures blood sugar levels safely compared to standard methods.
MariborAges 18 years+ - NCT07440706Recruiting
Glucose monitor for late dumping symptoms after bypass
This study tests a continuous glucose monitor (a small sensor that tracks your blood sugar) to see if it helps manage symptoms of late dumping syndrome—a condition causing low blood sugar after meals—in people who had gastric bypass surgery at least a year ago.
São José do Rio Preto, São PauloAges 18–65 - NCT07394075Enrolling by invitation
CGM support for type 2 diabetes management
This trial tests whether using continuous glucose monitor (CGM) data can help doctors and patients better manage type 2 diabetes. It is for people who already use insulin and a CGM device to check their blood sugar levels.
Minneapolis, MinnesotaAges 18–75 - NCT07386340Recruiting
Testing a new continuous glucose monitor with flash readings
This study tests a new sensor system that tracks glucose levels continuously and can give a quick reading when you wave a device over it. It aims to see if it's safe and accurate for people with diabetes.
Escondido, CaliforniaAges 18 years+ - NCT07296276Recruiting
Testing the CareSens Air 3 glucose monitor in type 1 diabetes
This study tests how accurate a new continuous glucose monitor (CGM) called CareSens Air 3 is for adults with type 1 diabetes. You would wear the sensor on your skin to track blood sugar levels, and it may help you manage your diabetes more easily.
Escondido, CaliforniaAges 18–65 - NCT04201600Recruiting
Study how blood sugar swings affect thinking in prediabetes
This study looks at how “blood sugar variability” (how much glucose levels bounce around) may affect thinking and memory in people with prediabetes. You may be eligible if you’re older and don’t already have diabetes or conditions that can strongly affect the brain or blood vessels.
Baltimore, MarylandAges 50 years+ - NCT07251257Recruiting
Continuous glucose monitor study for seafarers with diabetes
This trial tests if wearing a continuous glucose monitor (CGM) for 12 months helps seafarers on insulin better manage their blood sugar levels while at sea. You'll also use an app to log readings and activities.
Guildford, SurreyAges 18 years+ - NCT07184775Recruiting
CGM vs finger-stick for type 2 diabetes in pregnancy
This trial tests if using a continuous glucose monitor (CGM) helps manage blood sugar better than finger-stick checks in pregnant women with type 2 diabetes. It aims to see if CGM leads to better sugar control and possibly healthier outcomes for you and your baby.
Sewell, New JerseyAges 18 years+ - NCT07139808Recruiting
A new glucose and ketone monitor for type 1 diabetes
This trial tests a new device that measures blood sugar and ketones continuously. It may help people with type 1 diabetes who use an insulin pump keep better track of their levels.
Shijiazhuang, HebeiAges 18 years+ - NCT07122180Enrolling by invitation
14-day study of a new continuous glucose monitor for diabetes
This study tests a new continuous glucose monitor (CGM) that you wear for 14 days. It checks how accurate the device is and how well it helps track your blood sugar levels, all while being safe and easy to use.
Riga, RigaAges 18–80 - NCT07108179Enrolling by invitation
Continuous glucose monitor accuracy in ICU patients
This trial tests a continuous glucose monitoring system for people in the intensive care unit (ICU). It checks how well the device measures blood sugar and if it can help predict outcomes for critically ill patients.
Changsha, changshaAges 18 years+ - NCT07092761Recruiting
Testing a new continuous glucose monitor
This study tests a new continuous glucose monitor that checks your blood sugar levels in real time. It aims to see how accurate and safe it is for people with diabetes.
Luoyang, HenanAges 18 years+ - NCT07007676Recruiting
Continuous glucose monitor for older adults with type 2 diabetes
This trial tests if using a continuous glucose monitor (CGM) helps older adults with type 2 diabetes who are not on insulin to better control their blood sugar. The results will show if CGM is a helpful tool for managing diabetes without daily shots.
Shenzhen, GuandongAges 60 years+ - NCT06904846Enrolling by invitation
Testing a new continuous glucose monitor for 60 days
This study tests a new continuous glucose monitor (CGM) called iCan o3 that you wear on your abdomen for 60 days. It helps track your blood sugar levels continuously, so you and your doctor can see patterns and make better decisions about your diabetes care.
AntwerpAges 18–75
Hear when a new Continuous Glucose Monitoring System trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for continuous glucose monitoring system?
- Yes. Clin2 currently lists 38 recruiting continuous glucose monitoring system studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a continuous glucose monitoring system trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a continuous glucose monitoring system trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.